cas 1943-79-9|| where to buy Phenyl methylcarbamate

Nom du produit:Phenyl methylcarbamate

IUPAC Name:phenyl N-methylcarbamate

Unité d'emballage	Stock disponible	Prix($)
CM538155-1g	in stock	ŪȖ
CM538155-5g	in stock	Ɛǫƴ
CM538155-10g	in stock	ƴȖƴ
CM538155-25g	in stock	ȖŪƚ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1943-79-9 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:1943-79-9; Formule moléculaire:C8H9NO2; Point de fusion:-; Code SMILES:O=C(OC1=CC=CC=C1)NC; Densité:

: Numéro de catalogue:CM538155; Poids moléculaire:151.17; Point d'ébullition:; N° Mdl:MFCD01738783; Stockage:

: Benzenes; Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

: Tasurgratinib; Eisai announced that it has obtained manufacturing and marketing approval for fibroblast growth factor receptor (FGFR) selective tyrosine kinase inhibitor ‘TASFYGO® Tablets 35mg’ (tasurgratinib succinate) in Japan for the treatment of patients with unresectable biliary tract cancer with FGFR2 gene fusions or rearrangements that progressed after cancer chemotherapy. In Japan, it has received orphan drug designation from the Ministry of Health, Labour and Welfare (MHLW), and the marketing authorization application was submitted in December 2023. TASFYGO is an orally available novel tyrosine kinase inhibitor that demonstrates selective inhibitory activity against fibroblast growth factor receptors (FGFR) FGFR1, FGFR2 and FGFR3.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.